Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miltefosine in Post Kala Azar Dermal Leishmaniasis
NCT01635777Phase 2Completed
- Sponsor
- The A.B. Foundation for Medical Research
- Start
- Jul 2007
- Primary completion
- Oct 2009
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of miltefosine in Post kala-azar dermal leishmaniasis (PKDL), sponsored by The A.B. Foundation for Medical Research. Started Jul 2007; status: completed.
02
Drugs
miltefosine
03
Conditions
Post kala-azar dermal leishmaniasis (PKDL)
Beyond the preview
Go deeper on NCT01635777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01635777.